Barriers to a trial of atherosclerosis prevention in systemic lupus erythematosus.


OBJECTIVE The effectiveness of aggressive management of traditional risk factors for accelerated atherosclerosis in systemic lupus erythematosus (SLE) has been advocated but not proven. We conducted a pilot, randomized, controlled trial of known prevention medications (pravastatin, ramipril, aspirin, and a combination B vitamin) plus individualized… (More)


  • Presentations referencing similar topics